Literature DB >> 15754036

Ghrelin, peptide YY and their receptors: gene expression in brain from subjects with and without Prader-Willi syndrome.

Zohreh Talebizadeh1, Nataliya Kibiryeva, Douglas C Bittel, Merlin G Butler.   

Abstract

Ghrelin and peptide YY (PYY) are peptides generally produced by the gastrointestinal organs which are involved in appetite regulation via highly specialized centers in the brain. Abnormal plasma ghrelin and PYY levels compared with controls have been reported for subjects with Prader-Willi syndrome (PWS) which is characterized by infantile hypotonia, poor suck reflex and failure to thrive followed by hyperphagia and marked obesity in early childhood. We studied gene expression of ghrelin, peptide YY, and their receptors (i.e., GHS-R1a, GHS-R1b, and NPY2R) in six different brain regions (frontal cortex, temporal cortex, visual cortex, pons, medulla, and hypothalamus) obtained from three subjects with PWS, two individuals with Angelman syndrome, and six controls to determine if expression of these genes is detectable in different regions of the brain in subjects with and without PWS. In general, expression of these genes using RT-PCR was detected in all subjects and no obvious differences were seen in their pattern of expression between subjects with or without PWS. Additional studies including quantitative gene expression measurements will be required to further evaluate the role of these genes in the eating disorder seen in PWS.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15754036      PMCID: PMC5459610     

Source DB:  PubMed          Journal:  Int J Mol Med        ISSN: 1107-3756            Impact factor:   4.101


  15 in total

Review 1.  Central nervous system control of food intake.

Authors:  M W Schwartz; S C Woods; D Porte; R J Seeley; D G Baskin
Journal:  Nature       Date:  2000-04-06       Impact factor: 49.962

2.  The expression of the growth hormone secretagogue receptor ligand ghrelin in normal and abnormal human pituitary and other neuroendocrine tumors.

Authors:  M Korbonits; S A Bustin; M Kojima; S Jordan; E F Adams; D G Lowe; K Kangawa; A B Grossman
Journal:  J Clin Endocrinol Metab       Date:  2001-02       Impact factor: 5.958

3.  Plasma peptide YY and ghrelin levels in infants and children with Prader-Willi syndrome.

Authors:  Merlin G Butler; Douglas C Bittel; Zohreh Talebizadeh
Journal:  J Pediatr Endocrinol Metab       Date:  2004-09       Impact factor: 1.634

4.  Ghrelin and growth hormone secretagogue receptor are expressed in the rat adrenal cortex: Evidence that ghrelin stimulates the growth, but not the secretory activity of adrenal cells.

Authors:  Paola G Andreis; Ludwik K Malendowicz; Marcin Trejter; Giuliano Neri; Raffaella Spinazzi; Gian Paolo Rossi; Gastone G Nussdorfer
Journal:  FEBS Lett       Date:  2003-02-11       Impact factor: 4.124

5.  Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery.

Authors:  David E Cummings; David S Weigle; R Scott Frayo; Patricia A Breen; Marina K Ma; E Patchen Dellinger; Jonathan Q Purnell
Journal:  N Engl J Med       Date:  2002-05-23       Impact factor: 91.245

6.  Developmental, stage-specific, and hormonally regulated expression of growth hormone secretagogue receptor messenger RNA in rat testis.

Authors:  M L Barreiro; J S Suominen; F Gaytán; L Pinilla; L K Chopin; F F Casanueva; C Diéguez; E Aguilar; J Toppari; M Tena-Sempere
Journal:  Biol Reprod       Date:  2002-11-27       Impact factor: 4.285

7.  Prader-Willi Syndrome: Clinical and Genetic Findings.

Authors:  Merlin G Butler; Travis Thompson
Journal:  Endocrinologist       Date:  2000-07

8.  Serum ghrelin levels are inversely correlated with body mass index, age, and insulin concentrations in normal children and are markedly increased in Prader-Willi syndrome.

Authors:  Andrea M Haqq; I Sadaf Farooqi; Stephen O'Rahilly; Diane D Stadler; Ron G Rosenfeld; Katherine L Pratt; Stephen H LaFranchi; Jonathan Q Purnell
Journal:  J Clin Endocrinol Metab       Date:  2003-01       Impact factor: 5.958

9.  A receptor in pituitary and hypothalamus that functions in growth hormone release.

Authors:  A D Howard; S D Feighner; D F Cully; J P Arena; P A Liberator; C I Rosenblum; M Hamelin; D L Hreniuk; O C Palyha; J Anderson; P S Paress; C Diaz; M Chou; K K Liu; K K McKee; S S Pong; L Y Chaung; A Elbrecht; M Dashkevicz; R Heavens; M Rigby; D J Sirinathsinghji; D C Dean; D G Melillo; A A Patchett; R Nargund; P R Griffin; J A DeMartino; S K Gupta; J M Schaeffer; R G Smith; L H Van der Ploeg
Journal:  Science       Date:  1996-08-16       Impact factor: 47.728

10.  Growth hormone secretagogue receptor subtypes 1a and 1b are expressed in the human adrenal cortex.

Authors:  Gianni Carraro; Giovanna Albertin; Abudujilili Abudukerimu; Francesco Aragona; Gastone G Nussdorfer
Journal:  Int J Mol Med       Date:  2004-02       Impact factor: 4.101

View more
  9 in total

1.  Potential role of hypothalamic ghrelin in the pathogenesis of human obesity.

Authors:  M E Couce; D Cottam; J Esplen; R Teijeiro; P Schauer; B Burguera
Journal:  J Endocrinol Invest       Date:  2006 Jul-Aug       Impact factor: 4.256

2.  Plasma obestatin and ghrelin levels in subjects with Prader-Willi syndrome.

Authors:  Merlin G Butler; Douglas C Bittel
Journal:  Am J Med Genet A       Date:  2007-03-01       Impact factor: 2.802

3.  Neural mechanisms underlying hyperphagia in Prader-Willi syndrome.

Authors:  Laura M Holsen; Jennifer R Zarcone; William M Brooks; Merlin G Butler; Travis I Thompson; Jasjit S Ahluwalia; Nicole L Nollen; Cary R Savage
Journal:  Obesity (Silver Spring)       Date:  2006-06       Impact factor: 5.002

4.  Ghrelin tissue distribution: comparison between gene and protein expression.

Authors:  S Ghelardoni; V Carnicelli; S Frascarelli; S Ronca-Testoni; R Zucchi
Journal:  J Endocrinol Invest       Date:  2006-02       Impact factor: 4.256

5.  A 9-year-old male with a duplication of chromosome 3p25.3p26.2: clinical report and gene expression analysis.

Authors:  Douglas C Bittel; Nataliya Kibiryeva; Majed Dasouki; Joan H M Knoll; Merlin G Butler
Journal:  Am J Med Genet A       Date:  2006-03-15       Impact factor: 2.802

Review 6.  Apo-Ghrelin Receptor (apo-GHSR1a) Regulates Dopamine Signaling in the Brain.

Authors:  Andras Kern; Cristina Grande; Roy G Smith
Journal:  Front Endocrinol (Lausanne)       Date:  2014-08-18       Impact factor: 5.555

Review 7.  Puzzle Pieces: Neural Structure and Function in Prader-Willi Syndrome.

Authors:  Katherine E Manning; Anthony J Holland
Journal:  Diseases       Date:  2015-12-17

Review 8.  Obesity in Prader-Willi syndrome: physiopathological mechanisms, nutritional and pharmacological approaches.

Authors:  G Muscogiuri; L Barrea; F Faggiano; M I Maiorino; M Parrillo; G Pugliese; R M Ruggeri; E Scarano; S Savastano; A Colao
Journal:  J Endocrinol Invest       Date:  2021-04-23       Impact factor: 4.256

9.  Cortical Transcriptomic Alterations in Association With Appetitive Neuropeptides and Body Mass Index in Posttraumatic Stress Disorder.

Authors:  Lauren A Stone; Matthew J Girgenti; Jiawei Wang; Dingjue Ji; Hongyu Zhao; John H Krystal; Ronald S Duman
Journal:  Int J Neuropsychopharmacol       Date:  2021-02-15       Impact factor: 5.176

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.